U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Subcutaneous implantable multiple agent delivery system

Patent 5443508 Issued on August 22, 1995. Estimated Expiration Date: Icon_subject November 12, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Subcutaneous implantable multiple-agent delivery system Patent #: 5201728
Issued on: 04/13/1993
Inventor: Giampapa

Inventor

Application

No. 151377 filed on 11/12/1993

US Classes:

623/23.72, Tissue424/424, Membrane or diffusion barrier424/425, Diffusion barrier is matrix604/891.1Implanted dynamic device or system

Examiners

Primary: Isabella, David J.
Assistant: Brittingham, Debra S.

Attorney, Agent or Firm

International Classes

A61F 002/02
A61K 009/22

Abstract

An implantable multiple-agent biologic delivery system includes a pod proportioned for subcutaneous implantation beneath the dermis of the skin, the pod including a porous surface and having at least one internal chamber which is in fluid communication with the porous surface. The system includes a dome proportioned for selectable detachable securement to the chamber of the pod. The dome includes interior chambers, each in fluid communication with the interior of the pod. Bio-acting agents, such as hormones, enzymes, biologic response modifiers, free radical scavengers, and other genetically altered cell cultures may be provided, within the chambers of the dome, prior to implantation. Such agents within the dome will, through the use of time release micropumps, enter the interior chambers of the pod for transmission, through the porous surfaces into a growth factor stimulated capillary matrix and then to the bloodstream of the user. The pod may be removed, refilled, and resecured to the dome upon exhaustion of its contents or upon medical requirement for changes in medication, or may be percutaneously refilled in situ through injection into the dome. The surface of the pod may be treated with one or more vascular growth factors or related biologic molecules.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?